Nucleotide changea | Amino acid changeb | Case no. | Control no. | SIFTc | PolyPhen2d | Sex | Age (weeks) | NTD type | MAF in cohort | MAF in CHB |
---|
c.G506 T | p. Gly169Val | 1 | 0 | 0.04 | 1 | F | 12 | anencephalus | 0.001845 | not reported |
c.A1104T | p. Glu368Asp | 1 | 1 | 0.25 | 0.003 | F | 24 | anencephalus | 0.00369 | 0.0049 |
- aFor nucleotide numbering, + 1 corresponds to the A of ATG of mRNA sequence 2. NM_017667.3
- bReference protein sequence NP_060137.2
- cThe threshold for intolerance is 0.05 and ranges from 0 to 1. The amino-acid substitution was predicted to be damaging if the score was <=0.05 and tolerated if the score was > 0.05
- dThe score is from 0 to 1; the amino-acid substitution was appraised qualitatively as benign or damaging based on pairs of false positive rate thresholds and optimized separately for each model